Are you looking to put a sizable chunk of cash to work generating investment income? Whether you intend to live on this income or reinvest it to bolster your portfolio's overall growth, there are seve

Final Trade: PFE, AFRM, LYFT, AEM

06:20pm, Monday, 04'th Aug 2025
The final trades of the day with CNBC's Melissa Lee and the "Fast Money" traders.
Let's look at five pharma and biotech companies, PFE, LLY, AMGN, GILD and NVO, which are scheduled to release their second-quarter 2025 results this week.
Shares of Pfizer ( NYSE: PFE ) lost 6.50% over the past month, bringing the stock's year-to-date loss to 11.31%.
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Pfizer's strong EPS surprise streak and positive earnings revisions are encouraging, but patent cliff risks remain a major concern for future growth. Valuation appears attractive with ratios below sec
Pfizer Inc. PFE will release earnings results for the second quarter before the opening bell on Tuesday, Aug. 5.

3 Top Dividend Stocks to Buy in August

12:48am, Monday, 04'th Aug 2025
In a market filled with volatility that seems less and less reliant on fundamentals with each passing day, risk-adverse investors may be better off looking for stocks that generate reliable streams of
We'll see another busy week for earnings , with reports also coming from BioNTech, GlobalFoundries, Rivia, Occidental, and many more.

The 3 Things That Matter for Pfizer Now

07:45am, Sunday, 03'rd Aug 2025
Once a market darling during the early pandemic years, Pfizer (PFE 0.84%) has been on a straight southbound path for several years now. The company's shares are down by 50% since 2022.
Pfizer (NYSE:PFE) is set to announce its earnings on Tuesday, August 5, 2025, prior to the market opening. Analyzing Pfizer's stock performance over the previous five years after earnings announcement
Pfizer and its German partner BioNTech on Friday lost their bid to overturn a ruling that their COVID-19 vaccine infringed one of Moderna's patents at London's Court of Appeal.
Measures laid out in letters to 17 companies would either have modest impact or face legal challenges, say industry experts.
PFE eyes Q2 earnings beat as strength in Vyndaqel and Padcev is expected to offset declines from Eliquis, Ibrance and Prevnar.
Former FDA Commissioner Dr. Scott Gottlieb joins 'Squawk Box' to discuss news of President Trump ordering pharma companies to lower U.S. drug prices in the next 60 days, the move to tiered pricing glo
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE